MorphoSys AG (MOR)
17.89
+0.02
(+0.11%)
USD |
NASDAQ |
May 03, 16:00
17.90
+0.01
(+0.06%)
After-Hours: 20:00
MorphoSys Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -138.53M |
| March 31, 2023 | -76.51M |
| June 30, 2022 | -92.15M |
| March 31, 2022 | -161.37M |
| December 31, 2021 | -187.67M |
| September 30, 2021 | -223.38M |
| June 30, 2021 | -107.71M |
| March 31, 2021 | -50.88M |
| December 31, 2020 | -81.87M |
| September 30, 2020 | -42.79M |
| June 30, 2020 | -66.77M |
| March 31, 2020 | 231.70M |
| December 31, 2019 | -46.70M |
| September 30, 2019 | 5.669M |
| June 30, 2019 | -23.29M |
| March 31, 2019 | -26.44M |
| December 31, 2018 | -28.61M |
| September 30, 2018 | 36.05M |
| June 30, 2018 | -14.43M |
| March 31, 2018 | -31.72M |
| December 31, 2017 | -4.44M |
| September 30, 2017 | -7.294M |
| June 30, 2017 | -22.22M |
| March 31, 2017 | -9.588M |
| December 31, 2016 | -20.33M |
| Date | Value |
|---|---|
| September 30, 2016 | -13.08M |
| June 30, 2016 | -8.496M |
| March 31, 2016 | -9.682M |
| December 31, 2015 | -21.89M |
| September 30, 2015 | -5.459M |
| June 30, 2015 | -1.748M |
| March 31, 2015 | 3.006M |
| December 31, 2014 | -14.53M |
| September 30, 2014 | 9.157M |
| June 30, 2014 | -2.922M |
| March 31, 2014 | -10.61M |
| December 31, 2013 | -15.18M |
| September 30, 2013 | 133.32M |
| June 30, 2013 | -7.369M |
| March 31, 2013 | 7.616M |
| December 31, 2012 | -0.7585M |
| September 30, 2012 | 4.616M |
| June 30, 2012 | -4.521M |
| March 31, 2012 | 2.965M |
| December 31, 2011 | -13.24M |
| September 30, 2011 | 4.28M |
| June 30, 2011 | 31.03M |
| March 31, 2011 | 15.68M |
| December 31, 2010 | -7.862M |
| September 30, 2010 | -25.97M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-223.38M
Minimum
Sep 2021
231.70M
Maximum
Mar 2020
-70.82M
Average
-76.51M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Incyte Corp | 218.81M |
| Novartis AG | 2.265B |
| Immatics NV | 85.99M |
| Affimed NV | -27.02M |
| InflaRx NV | -11.61M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -19.30% |